RenovoRx, Inc. (RNXT)

RenovoRx Revenue

In the year 2025, RenovoRx had annual revenue of $1.12M with 2,511.63% growth. RenovoRx had revenue of $238.00K in the quarter ending December 31, 2025, with 453.49% growth.

• Revenue (ttm): $1.12M
• Revenue Growth: +2,511.63%
• P/S Ratio: 34.04
• Revenue / Employee: $66,059
• Employees: 17
• Market Cap: 39.27M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.12M	1.08M	2,511.63%
Dec 31, 2024	43.00K	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 14, 2026

Data Sources Report a data error